earnings
NV
NYSE · NVS
Novartis AG
Healthcare · Drug Manufacturers - General
$140.37
Down-$0.55 (-0.39%)
Updated Sep 20, 2026, 10:04 AM
SID Score
5.9/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 258.98B
- P/E ratio
- 18.18
- Dividend yield
- 2.85%
- 52-week range
- $121.57 – $170.46
- Volume
- 2.25M
- Avg. volume
- 1.65M
Price performance
NVS price history
1M range · 19 trading sessions · Daily adjusted prices
NVS closed at $140.37 after 19 trading sessions, down 11.17% for the selected period.
- Last close
- $140.37
- Period change
- -11.17%
- Period low
- $137.16
- Period high
- $163.09
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $140.87 | $141.15 | $139.60 | $140.37 | 2.25M |
| Sep 17, 2026 | $140.12 | $141.21 | $139.97 | $140.92 | 1.71M |
| Sep 16, 2026 | $140.58 | $141.46 | $138.28 | $138.70 | 1.89M |
| Sep 15, 2026 | $138.76 | $139.11 | $137.37 | $138.62 | 2.37M |
| Sep 14, 2026 | $141.64 | $141.64 | $138.99 | $138.99 | 2.48M |
| Sep 11, 2026 | $139.31 | $139.55 | $137.00 | $137.16 | 2.35M |
| Sep 10, 2026 | $138.76 | $139.43 | $137.46 | $137.48 | 2.42M |
| Sep 9, 2026 | $138.14 | $139.45 | $137.30 | $137.48 | 2.94M |
| Sep 8, 2026 | $139.94 | $140.46 | $137.115 | $137.70 | 10.27M |
| Sep 4, 2026 | $159.90 | $160.93 | $159.625 | $159.99 | 1.29M |
| Sep 3, 2026 | $164.48 | $164.48 | $161.42 | $163.09 | 2.45M |
| Sep 2, 2026 | $160.80 | $163.18 | $160.38 | $162.46 | 4.34M |
| Sep 1, 2026 | $162.15 | $163.57 | $160.21 | $161.25 | 4.33M |
| Aug 31, 2026 | $152.60 | $152.74 | $151.685 | $152.06 | 1.29M |
| Aug 28, 2026 | $154.51 | $154.565 | $152.77 | $153.81 | 1.17M |
| Aug 27, 2026 | $155.925 | $155.93 | $154.43 | $154.65 | 1.22M |
| Aug 26, 2026 | $158.41 | $159.19 | $157.44 | $157.54 | 1.47M |
| Aug 25, 2026 | $158.51 | $160.29 | $157.83 | $159.98 | 998.18K |
| Aug 24, 2026 | $157.12 | $158.46 | $156.77 | $158.02 | 801.26K |
Latest NVS news
The latest Smart Investors Daily articles mentioning NVS.
Stock researchMarket Activity · Institutional Ownership
Loading stock research…